Testosterone: Nursing Guide
Serum testosterone answers whether androgen levels fit the clinical picture — low libido and fatigue in men, hirsutism and irregular cycles in women, puberty timing in adolescents, or therapy monitoring after replacement or antiandrogen treatment. Nurses protect interpretation by confirming morning draw timing when ordered, documenting topical or injectable androgen medicines, and avoiding single-value diagnoses of hypogonadism or PCOS before the prescriber reviews the full panel.
Contents
Quick Facts
Key Takeaway
Testosterone is highest in the morning in males — a mistimed draw or unreported androgen gel can change how a result is read as much as the number itself.
Specimen & Collection Details
Nurse quick-reference for collection prep that affects result quality.
Red top (serum) — gold-top/SST may be acceptable at some laboratories
Serum without gel separator preferred for some mass-spectrometry panels per the reporting laboratory; follow the reporting laboratory specimen list
Serum (venipuncture; tube type per reporting laboratory)
Approximately 1–2.5 mL serum after separation — follow the reporting laboratory minimum
blood is commonly drawn in the morning between 7:00 and 10:00 a.m. when testosterone is typically highest; label exact collection time on the requisition
Fasting may be required in certain cases; follow the ordering clinician’s and laboratory’s instructions — do not stop medicines unless instructed
Centrifuge and aliquot serum into a plastic vial when required; refrigerate or freeze per institutional and laboratory stability policy
Commonly same day to 48 hours; varies by institution and assay
Endocrine / chemistry laboratory or send-out reference laboratory
What is Testosterone?
Testosterone measures testosterone — the major androgenic hormone — in a blood sample. Most orders measure total testosterone (bound plus free). Free or bioavailable testosterone may be added when sex hormone-binding globulin (SHBG) abnormalities or mild homeostasis changes are suspected. In males, testosterone supports sperm production, muscle and bone health, and secondary sexual characteristics. In females, smaller amounts influence libido and serve as an estrogen precursor. The test helps evaluate hypogonadism, hyperandrogenism, puberty disorders, infertility workups, and androgen therapy monitoring when interpreted with age, sex, symptoms, and companion tests.
Overview
Nurses see testosterone during workups for fatigue, erectile dysfunction, infertility concerns, hirsutism, and irregular periods. standard clinical references emphasize that a testosterone level test alone cannot diagnose any condition — abnormal results with compatible symptoms may prompt further evaluation. In men, the test is most often used for suspected low testosterone; in women, for suspected high testosterone patterns such as polycystic ovary syndrome (PCOS).
Morning collection between 7:00 and 10:00 a.m. is commonly requested because testosterone follows a diurnal pattern in males. Topical gels, injections, anabolic steroids, estrogen therapy, and acute illness can alter results. When total testosterone is borderline, laboratories may recommend free or bioavailable testing per the reporting laboratory guidance — especially in older men, women with hyperandrogenic symptoms and normal totals, or when SHBG is abnormal. Nurses coordinate paired DHEA-S or semen analysis when ordered and monitor acne or virilization progression while results are pending.
Before venipuncture, confirm whether total, free, or bioavailable testosterone is ordered, verify morning timing when specified, document all androgen medicines (including gels and supplements), record patient age and sex for reference matching, and escalate rapid virilization, severe hypertension, or hemodynamic instability according to facility policy — do not defer urgent care for pending testosterone alone.
Morning Draw Timing and Androgen Interpretation Safety
Serum testosterone is widely ordered but easily misread when collection time, exogenous androgen medicines, or the wrong assay (total vs free) are ignored. In men, a sample drawn at 3 p.m. is not interchangeable with an 8 a.m. morning testosterone. Rapid virilization and acute scrotal pain outrank pending hormone results.
- Afternoon draw submitted as morning testosterone without prescriber-approved timing change
- Undisclosed topical testosterone gel or anabolic steroid use before a diagnostic baseline draw
- Rapid virilization, clitoromegaly, or severe hypertension — escalate per facility policy
- Labeling hypogonadism or PCOS from a single testosterone value without repeat testing and prescriber review
Document: age, sex, collection clock time, androgen medicine exposure, assay type ordered, paired hormone tests, symptom progression, and prescriber notifications.
What Serum Testosterone Can and Cannot Tell You
This test can help identify:
- Circulating androgen levels when interpreted with age-, sex-, and time-matched reference intervals
- Patterns compatible with male hypogonadism, female hyperandrogenism, or puberty disorders alongside symptoms
- Need for free or bioavailable testing when total testosterone and symptoms disagree
- Trend data during testosterone replacement or antiandrogen therapy monitoring
This test cannot:
- Diagnose hypogonadism, PCOS, testicular failure, or androgen-secreting tumors by itself (standard clinical references)
- Replace LH, FSH, DHEA-S, prolactin, semen analysis, or imaging when those are the ordered questions
- Confirm infertility cause without paired reproductive evaluation
- Validate unregulated supplement claims — OTC testosterone boosters are not reliable diagnostic or treatment tools
Pre-draw Checks for Timed Testosterone Specimens
Verify
Clarify before proceeding when:
- Order lists morning testosterone but clinic schedule only permits afternoon phlebotomy
- Patient reports testosterone gel or anabolic steroid use not on the medication list
- Pediatric patient but only adult reference interval is available on the requisition
- Free or bioavailable testing is clinically needed but only total testosterone is ordered per prescriber plan
- Rapid virilization or acute scrotal pain is present during routine outpatient draw planning
- Specimen label demographics do not match the patient at the bedside
- Prior testosterone was drawn at the wrong time or rejected — confirm repeat protocol
Total, Free, and Bioavailable Testosterone Patterns
Most orders measure total testosterone. the reporting laboratory notes free or bioavailable testing when SHBG is abnormal, when totals are borderline with symptoms, in older men, or in women with hyperandrogenic symptoms and normal totals.
| Pattern (general) | May suggest | Nursing focus |
|---|---|---|
| Low total testosterone + compatible male symptoms | Hypogonadism workup — repeat morning testing often required | Document timing and medicines; support urology/endocrine follow-up |
| Normal total + hyperandrogenic symptoms (women) | Consider free/bioavailable testing or SHBG review | Avoid false reassurance; notify prescriber for additional orders |
| High testosterone + rapid virilization | Urgent androgen excess evaluation | Escalate per protocol; monitor BP and symptom pace |
| Low testosterone during documented replacement therapy | Absorption, adherence, or dosing question | Document application site, last dose time, and prescriber notification |
Reading Total, Free, and Bioavailable Testosterone With Symptoms
Integrate testosterone with libido, menstrual history, hirsutism distribution, muscle changes, fertility goals, collection time, and paired DHEA-S or LH when ordered. Pediatric and adult ranges are not interchangeable, and age-related decline in men requires symptom correlation — not automatic treatment from one low value.
| Clinical context | Result pattern | Nursing action |
|---|---|---|
| Male fatigue + low libido | Low morning total testosterone on repeat sampling | Support endocrine/urology pathway; teach realistic therapy expectations |
| Woman with hirsutism + oligomenorrhea | Elevated testosterone with compatible exam | Monitor BP, glucose risk factors; avoid labeling PCOS without prescriber |
| Therapy monitoring | Target range per prescriber on treated patient | Document dose timing; report supratherapeutic or subtherapeutic trends |
| Mistimed afternoon draw in male | Low total testosterone | Notify prescriber; clarify repeat morning collection before major decisions |
Testosterone Testing in Hypogonadism and PCOS Workups
Diagnostic safety badge: Critical-result test — prompt review and escalation may be required when androgen excess progresses rapidly or when acute scrotal pain suggests torsion or tumor complication.
Check-before-test protocol
- Identity + correct testosterone assay and morning timing when ordered
- Androgen medicine and supplement history documented
- Age and sex verified on requisition for reference matching
- Serum tube and transport requirements confirmed with laboratory
- Symptom and BP assessment before outpatient collection
Critical teach-back questions
- “Can you tell me why this blood test may need to be done in the morning?”
- “What gels, injections, or supplements have you used in the last week?”
- “What scrotal pain, voice changes, or severe headache should you report right away?”
Care coordination: endocrinology, urology, laboratory/phlebotomy, fertility clinic, and rapid response per institutional protocol.
Why Testosterone is Ordered
Testosterone is ordered when clinicians need objective androgen data to explain symptoms, evaluate puberty, investigate infertility, or monitor therapy.
| Clinical Indication | What the Test Answers | Nursing Rationale |
|---|---|---|
| Suspected male hypogonadism or low testosterone symptoms after puberty | Do symptoms align with low circulating androgen levels? | standard clinical references lists low sex drive, erectile dysfunction, infertility, reduced body hair, anemia, and muscle loss as male indications — interpreted with age and repeat testing. |
| Suspected androgen excess in women (hirsutism, acne, menstrual irregularity) | Is ovarian or adrenal androgen contribution elevated? | High testosterone patterns may accompany PCOS, ovarian disorders, or adrenal conditions per reviewed references — not diagnostic from one value alone. |
| Puberty timing evaluation in children and adolescents | Is puberty early, delayed, or consistent with androgen levels? | Pediatric endocrine pathways use age- and sex-specific reference intervals; nurses must confirm demographics on the requisition. |
| Monitoring testosterone or antiandrogen therapy | Is the current regimen producing target androgen levels safely? | the reporting laboratory cites monitoring during replacement or antiandrogen therapy — nurses document last dose timing and application site for topical products. |
Contraindications and Precautions
There is no absolute contraindication to venipuncture for testosterone, but nurses should clarify the order when timing, medicine exposure, or missing age/sex documentation would impair interpretation.
- Rapid virilization, clitoromegaly, or severe hypertension with marked androgen excess — escalate per facility policy while endocrine workup continues.
- Suspected testicular or adrenal tumor with acute pain, hemodynamic instability, or neurologic change — urgent prescriber notification per protocol.
- Interpreting a single low morning testosterone as definitive hypogonadism without repeat testing, symptom correlation, or prescriber review.
- Afternoon draws when morning testing was ordered can falsely lower male results — document clock time and clarify repeat collection.
- Topical testosterone, anabolic steroids, and some supplements alter measured values — document exposure and last application time.
- Normal total testosterone with hyperandrogenic symptoms may still require free or bioavailable testing when SHBG is high — follow laboratory and prescriber guidance.
- Rapid progression of masculine features, severe hypertension, or acute abdominal pain with androgen excess pattern — escalate according to facility policy.
- Critical or markedly abnormal testosterone with unstable vitals, syncope, or new neurologic symptoms — urgent team notification per protocol.
- Result markedly discordant with clinical picture after undisclosed androgen therapy or specimen labeling error — clarify and repeat per laboratory guidance.
Patient Preparation
Preparation focuses on morning timing when ordered, medicine and supplement review, fasting instructions if specified, and accurate demographics for reference matching.
Pre-test checksReview topical and injectable testosterone, anabolic steroids, antiandrogens, estrogen-containing medicines, opioids, glucocorticoids, and OTC hormone supplements. Do not stop prescribed medicines unless the ordering clinician instructs — document what the patient actually took and when.
Performance — nursing procedure guide
This page is a Tests & Diagnostics guide for Testosterone. It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).
Step-by-step technique, supplies, infection prevention, and immediate post-procedure monitoring for this test are covered in:
Use the Patient preparation, Results and interpretation, and Nursing responsibilities sections on this page for order verification, pre-analytic checks, result follow-up, critical-value escalation, and documentation.
Result follow-up at a glance
Nursing workflow on this page — from order to safe action on results:
Results and Interpretation
Testosterone is commonly reported in ng/dL (or nmol/L). Interpretation requires the reporting laboratory’s age- and sex-specific reference interval, assay type (total vs free), symptoms, and paired hormone results.
Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.
| Result | Range / Finding | Clinical Meaning | Nursing Action |
|---|---|---|---|
| Within reference interval | Within reporting laboratory age- and sex-specific reference interval | Androgen level consistent with expected range for patient age and sex in clinical context | Continue planned workup if symptoms persist; avoid over-reassurance without clinical correlation |
| Borderline / near reference limit | Near lower or upper reference limit for age and sex | May require repeat morning sampling, free/bioavailable testing, or specialist interpretation | Ensure timing and medicine history were documented; notify prescriber for follow-up per protocol |
| High / above reference interval | Above laboratory age- and sex-specific reference interval | In women may suggest PCOS, ovarian or adrenal disorders, or androgen-secreting tumor — not diagnostic alone; in men may reflect supplementation, tumor, or adrenal disorder | Notify prescriber/endocrine team; monitor BP, menstrual changes, virilization pace, and mood |
| Low / below reference interval | Below laboratory age- and sex-specific reference interval | In men may support hypogonadism workup when symptoms align; age-related decline may be physiologic — repeat testing often required per guidelines | Assess libido, mood, muscle strength, and anemia symptoms; notify prescriber; clarify therapy plan |
Urgent Androgen Excess and Hypogonadism Escalation
Universal numeric critical-value thresholds for serum testosterone are Turnaround and screening rules vary by institution; follow local institutional policy. Urgent nursing action depends on symptom velocity, virilization, blood pressure, hemodynamic status, therapy context, and local laboratory critical-result policy.
| Critical Finding | Threshold / Value | Immediate Action |
|---|---|---|
| Rapid virilization or severe hypertension with androgen excess pattern | Clinical deterioration or marked androgenization — testosterone may be elevated but treatment timing is clinical | Escalate according to facility policy; continue vitals and symptom monitoring; support urgent endocrine or emergency pathway per prescriber |
| Marked hypotension, syncope, or acute testicular pain with abnormal androgen pattern | Hemodynamic instability, torsion concern, or tumor complication suspected | Urgent prescriber notification and monitoring per institutional protocol — do not wait for additional hormone results alone |
| Specimen or medicine context invalidates interpretation | Wrong patient label, undisclosed topical testosterone before diagnostic draw, or afternoon sample submitted as morning testosterone | Notify laboratory and prescriber; repeat collection and document medicine exposure before major treatment decisions |
Stop routine reassurance and escalate according to facility policy when virilization progresses rapidly, when hemodynamic instability or acute scrotal pain appears, or when results were interpreted without correct timing, age, sex, or androgen medicine context.
Factors Affecting Results
Testosterone varies by time of day, age, sex, SHBG, and medicines. Nurses prevent misclassification by documenting context before the draw.
- Apparent elevation from exogenous testosterone, anabolic steroids, or undisclosed supplements
- Recent testosterone gel application before a diagnostic draw intended to assess baseline production
- Using incorrect age or sex reference interval on the laboratory report
- Afternoon draw in a male when morning peak was required — may falsely suggest low testosterone
- Normal total testosterone despite symptoms when SHBG elevation lowers bioavailable androgen
- Assay interference on some immunoassay platforms — mass spectrometry may be recommended per laboratory
- Collection time (morning vs afternoon diurnal variation in males)
- Topical/injectable testosterone, anabolic steroids, and hormone supplements
- Age, sex, SHBG, estrogen therapy, obesity, and acute illness
Testosterone alone does not diagnose hypogonadism, PCOS, testicular failure, or androgen-secreting tumors. the test cannot diagnose any health condition by itself. Confirmation requires repeat testing, symptoms, physical examination, and often LH, FSH, prolactin, DHEA-S, or imaging per prescriber plan.
Nursing Responsibilities
Nursing responsibilities center on timed collection, androgen medicine screening, demographic verification, and communicating results without overcalling diagnoses.
Before the TestDocumentation
Documentation should support correct interpretation and endocrine or urology follow-up.
“Serum total testosterone drawn 08:12 into red-top tube; centrifuged and aliquoted per protocol. Patient age 54 years documented on requisition. Reports nightly testosterone gel to inner thighs — last applied 06:30 today; prescriber aware therapy continues. Denies anabolic steroid use. Paired LH pending same visit. Mild fatigue unchanged. Prescriber notified of pending results.”
- Exact date and time of collection (morning draw verification)
- Patient age, sex, and pubertal context when relevant
- Androgen medicines, supplements, and last dose/application time
- Assay ordered (total vs free), tube type, and paired tests drawn
- Androgen symptom progression, BP, and scrotal or pelvic complaints
- Result notification and prescriber communication read-back if required
Patient and Family Education
Use plain language while keeping endocrine follow-up and repeat-testing expectations clear.
Testosterone NCLEX practice questions
Practice NCLEX-style clinical judgment focused on Testosterone safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.
Select a tab to view orders, results, assessment, and nursing note details for this case.
- Order: Serum total testosterone — male hypogonadism panel
- Indication: 54-year-old man with fatigue, low libido, and prior total testosterone below reference
- Timing: Morning draw requested; specimen collected at 14:45 without prescriber order change
- Related orders: LH; repeat morning total testosterone; semen analysis if infertility workup continues
- Result: Prior total testosterone 248 ng/dL (below laboratory reference); today’s sample pending
- Trend / prior value: Fatigue stable 3 months; no scrotal pain; BP 132/84 mmHg today
- Pending tests: Urology follow-up after repeat morning panel
- Vital signs: HR 76/min, BP 132/84 mmHg, temp 36.8°C, SpO₂ 98% on room air
- Symptoms: Fatigue, reduced libido, stable muscle strength, no gynecomastia
- Focused assessment: Testes descended bilaterally; no scrotal tenderness; BMI 29
- Preparation notes: Admission list incomplete — patient reports nightly testosterone gel not yet charted
- Collection events: Red-top serum collected 14:45; patient ate lunch at 12:30; morning timing not documented as prescriber-approved change
- Teaching gaps / safety concerns: Undocumented topical testosterone may alter interpretation; afternoon draw vs morning order; prior low testosterone on chart
Answer key & rationale
Frequently Asked Questions
FAQ
Why is testosterone ordered in men with fatigue or low libido?
standard clinical references lists low sex drive, erectile dysfunction, infertility, reduced body hair, anemia, and muscle loss as male indications for testing when hypogonadism is suspected — always interpreted with symptoms and repeat testing when appropriate.
Does the patient need a morning blood draw for testosterone?
providers commonly draw blood in the morning between 7:00 and 10:00 a.m. when testosterone is typically highest in males. Follow the specific order and laboratory instructions for timing.
Can testosterone gel or injections affect the result?
Yes. Exogenous testosterone and anabolic steroids can alter measured values. Nurses should document all androgen medicines and last application or injection time before collection and not stop prescribed therapy unless the clinician instructs.
What can a high testosterone result mean in women?
standard clinical references lists possible causes including PCOS, ovarian disorders, adrenal conditions such as congenital adrenal hyperplasia, and pituitary disorders. Interpretation requires symptoms, examination, and additional testing — not one result alone.
What can a low testosterone result mean in men?
Possible causes listed in reviewed references include testicular disorders, pituitary disease, chronic illness, alcohol use disorder, and genetic conditions such as Klinefelter syndrome. Levels also decrease with age — repeat morning testing and symptom correlation are often required.
When are free or bioavailable testosterone tests ordered?
the reporting laboratory recommends free or bioavailable testing when SHBG is abnormal, when total testosterone is borderline with symptoms, in older men, or in women with hyperandrogenic symptoms and normal totals — per prescriber and laboratory plan.
When should nurses escalate despite pending testosterone results?
Escalate according to facility policy when virilization progresses rapidly, when severe hypertension or acute scrotal pain appears, or when specimen context (timing, undisclosed androgen therapy) would mislead care — do not wait silently for testosterone alone.
References
References
-
MedlinePlus. Testosterone Levels Test. U.S. National Library of Medicine.https://medlineplus.gov/lab-tests/testosterone-levels-test/
-
Mayo Clinic Laboratories. Testosterone, Total and Free, Serum. Test Catalog.https://www.mayocliniclabs.com/test-catalog/overview/8508
-
Endocrine Society. Hypogonadism in Men. Hormone Health Network.https://www.endocrine.org/patient-engagement/endocrine-library/hypogonadism
-
Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. American Urological Association; 2018.https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
-
Office on Women’s Health. Polycystic Ovary Syndrome. U.S. Department of Health and Human Services.https://www.womenshealth.gov/a-z-topics/polycystic-ovary-syndrome
-
Nerenz RD, Boh B. Reproductive endocrinology and related disorders. In: Tietz Textbook of Laboratory Medicine. 7th ed. Elsevier; 2023.https://www.ncbi.nlm.nih.gov/books/NBK558918/
-
Duca Y, Aversa A, Condorelli RA, Calogero AE, La Vignera S. Substance Abuse and Male Hypogonadism. J Clin Med. 2019;8(5):732.https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6571549/
-
LabCorp. Testosterone, Total. Test Menu.https://www.labcorp.com/tests/004226/testosterone-total
Editorial Standards & Medical Review
About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.
Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for Testosterone.
Policies: Medical Review Process · Editorial Policy · Correction Policy